Table 2. Prevalence of anaemia in relation to IPTp doses taken.
Variable | anaemia at 36 weeks n (%) | N (%) | Test statistic | P-value | |
---|---|---|---|---|---|
717(62.6) 429(37.4) | 1146 | Pearson chi-square | |||
Reported SP use | Yes | No | |||
No SP | 169(72.8) | 63(27.2) | 232(100) | 12.0461 | 0.001 |
Took SP | 549(60.0) | 366(40.0) | 914(100) | ||
SP dosage | |||||
No SP | 169(72.8) | 63(27.2) | 232(100) | 28.2421 | <0.001 |
<3 | 285(66.6) | 143(33.4) | 428(100) | ||
≥3 | 263(54.1) | 223(45.9) | 486(100) |